ArticleInternational journal of cancer2019

Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist

Bogdan Mitran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.